CHARLES TOWN, W.Va., Oct. 18 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), an emerging medical device manufacturer founded by world-renowned medical device inventor David B. Phillips, Ph.D., today announced significant developments in ReBuilder's customer service organization and facilitation.
In an age when many companies are outsourcing customer service to overseas facilities, the Company is establishing an innovative customer- service system staffed by licensed medical professionals who can provide exceptional one-on-one telephone customer service to both potential and current customers.
The company has named Carol Faircloth, LPN, to oversee the organization and development of this new customer-service initiative. She will take on the task of recruiting and training the additional employees who are needed to fulfill ReBuilder's expanded customer service initiative. Faircloth brings a wealth of medical knowledge and customer service experience to the ReBuilder team. She spent the last 27 years of her career as a Licensed Professional Nurse.
By staffing its customer support team with employees who possess medical backgrounds and providing customers in need with instant access to licensed physicians, ReBuilder Medical Technologies, Inc., can further enhance value to its shareholders, and support the expected increase in customers resulting from its ongoing marketing efforts.
"In our 5 years of marketing the ReBuilder System(R) on the internet and handling call-in inquiries, we found that when a person calls in and can speak one-on-one with a medical professional, the closing ratio increases significantly," said ReBuilder CEO, David B. Phillips, Ph.D. "People today are much more likely to purchase technical equipment if they can discuss the proposed purchase with a knowledgeable and qualified representative," said Phillips.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery- powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.
More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward- looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
|SOURCE ReBuilder Medical Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved